Market Summary – Celltrion (068270.KS)
Celltrion traded up 0.1 % during the 24‑hour period ending at 10:04 AM Central Europe on Thursday, 22 October 2026.
- Current trading price: KRW 196,700 per share.
- Shares outstanding: 228.2 million.
- Market capitalization: KRW 45.1 trillion.
- Volume traded in the last 24 hours: KRW 118.9 billion.
Since the end of last month, the stock has risen 10.7 %. The 200‑day simple moving average is KRW 189,496.08. The 52‑week high was KRW 239,048 on 24 February 2026; the 52‑week low was KRW 158,500 on 8 June 2026.
Related Stock Activity (Last 24 Hours)
| Ticker | Company | % Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| 032830.KS | Samsung Life Insurance Lt | +3.38 % | KRW 241,500 | KRW 42.6 trillion | 17.98 |
| 028260.KS | Samsung C&T | +5.45 % | KRW 294,000 | KRW 44 trillion | 20.82 |
| 000270.KS | Kia | –1.69 % | KRW 109,100 | KRW 43.7 trillion | 6.65 |
| 005387.KS | Hyundai Motor | –1.07 % | KRW 162,200 | KRW 44 trillion | 11.02 |
| 006400.KS | Samsung SDI –144a Regs | –0.36 % | KRW 529,000 | KRW 43.3 trillion | – |
Hyundai Motor – Strategic Shift to Hybrid Vehicles
Hyundai Motor has announced a strategic shift toward hybrid vehicles, citing rising fuel costs and increasing consumer demand for fuel‑efficient options. The company plans to expand its hybrid lineup across multiple model segments and position hybrids as a core part of its future strategy. This move aligns with industry trends of expanding hybrid offerings to meet market demands and regulatory expectations. The announcement is expected to influence Hyundai’s product development roadmap and market positioning in the coming years.
Samsung SDI – Market Context
Samsung SDI shares fell in line with a broader decline across technology and battery‑manufacturing stocks. The decline reflected a weak trading day for the sector, influenced by mixed quarterly results and global concerns over artificial‑intelligence investments and high oil prices. Samsung SDI’s performance mirrored that of its peers, underscoring a broader challenge for the industry during the current trading session.
Company Overview – Celltrion Inc.
Celltrion Inc. is a healthcare biotechnology company headquartered in Incheon‑Si, South Korea. The company develops, manufactures, and sells biosimilar products and provides consignment processing services to other businesses. Celltrion is listed on the Korea Exchange Stock Market. Its initial public offering was conducted on 19 July 2005. More information can be found on the company’s website at www.celltrion.com .
